BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avedro, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-768-3400 Fax: 781-768-3401


SEARCH JOBS




Industry
Medical Device






 Company News
Avedro, Inc. Announces Resubmission Of New Drug Application To FDA For Corneal Cross-Linking 9/30/2014 11:15:47 AM
Avedro, Inc. Acquires Assets Of IROC Innocross AG, Including Its UV-X Line Of Cross-Linking Devices 9/3/2014 12:46:43 PM
Avedro, Inc. Becomes Exclusive Global Supplier Of MedioCROSS® Riboflavin For Corneal Cross-Linking 6/13/2014 8:06:21 AM
Avedro, Inc. Welcomes Robert J. Palmisano To Its Board Of Directors 5/14/2014 7:12:08 AM
Avedro, Inc. Announces Canadian Approval For Its KXL II™Advanced Cross-Linking System 4/23/2014 6:30:17 AM
FDA Asks For More Data On Avedro, Inc.'s Eye Therapy System 3/18/2014 8:49:39 AM
Avedro, Inc. To Present At Cowen and Company 34th Annual Health Care Conference 2/24/2014 6:54:10 AM
Avedro, Inc. Announces FDA Priority Review Status For Corneal Cross-linking New Drug Application 11/25/2013 8:19:25 AM
Avedro, Inc. And The University of Rostock (Germany) Announce Exclusive Intellectual Property Agreement 11/14/2013 9:55:01 AM
Avedro, Inc. Announces The Start Of Two New US FDA Trials for Accelerated Cross-linking 11/12/2013 8:57:22 AM
1234